GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Cyclically Adjusted Price-to-FCF

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Cyclically Adjusted Price-to-FCF : 109.88 (As of Jun. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-13), Shenzhen New Industries Biomedical Engineering Co's current share price is ¥74.72. Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was ¥0.68. Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF for today is 109.88.

The historical rank and industry rank for Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300832' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 70.65   Med: 106.03   Max: 121.57
Current: 113.07

During the past 12 years, Shenzhen New Industries Biomedical Engineering Co's highest Cyclically Adjusted Price-to-FCF was 121.57. The lowest was 70.65. And the median was 106.03.

SZSE:300832's Cyclically Adjusted Price-to-FCF is ranked worse than
86.44% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 42.85 vs SZSE:300832: 113.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shenzhen New Industries Biomedical Engineering Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was ¥1.395. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.68 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shenzhen New Industries Biomedical Engineering Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Cyclically Adjusted Price-to-FCF Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 90.92 93.39 115.74

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 115.74 -

Competitive Comparison of Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF falls into.



Shenzhen New Industries Biomedical Engineering Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=74.72/0.68
=109.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Shenzhen New Industries Biomedical Engineering Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.395/114.7809*114.7809
=1.395

Current CPI (Dec23) = 114.7809.

Shenzhen New Industries Biomedical Engineering Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.166 99.000 0.192
201512 0.269 100.600 0.307
201612 0.612 102.600 0.685
201712 0.495 104.500 0.544
201812 0.593 106.500 0.639
201912 0.717 111.200 0.740
202012 0.962 111.500 0.990
202112 0.547 113.108 0.555
202212 0.711 115.116 0.709
202312 1.395 114.781 1.395

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shenzhen New Industries Biomedical Engineering Co  (SZSE:300832) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shenzhen New Industries Biomedical Engineering Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Traded in Other Exchanges
N/A
Address
No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000
Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.
Executives
Ma Jie Supervisors
Ding Chen Liu Executives
Zhang Xiao Hong Executives
Zhang Lei Directors, executives
Li Ting Hua Executives
Liu Hai Yan Executives
Song Hong Tao Supervisors
Liu Peng Director
Jiang Li Li Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines